全文获取类型
收费全文 | 40850篇 |
免费 | 2489篇 |
国内免费 | 769篇 |
专业分类
耳鼻咽喉 | 158篇 |
儿科学 | 647篇 |
妇产科学 | 615篇 |
基础医学 | 3540篇 |
口腔科学 | 222篇 |
临床医学 | 3387篇 |
内科学 | 5612篇 |
皮肤病学 | 545篇 |
神经病学 | 1605篇 |
特种医学 | 700篇 |
外科学 | 2460篇 |
综合类 | 4912篇 |
现状与发展 | 3篇 |
预防医学 | 4455篇 |
眼科学 | 233篇 |
药学 | 11642篇 |
16篇 | |
中国医学 | 883篇 |
肿瘤学 | 2473篇 |
出版年
2023年 | 397篇 |
2022年 | 905篇 |
2021年 | 1282篇 |
2020年 | 1048篇 |
2019年 | 1037篇 |
2018年 | 1046篇 |
2017年 | 1055篇 |
2016年 | 1145篇 |
2015年 | 1332篇 |
2014年 | 2770篇 |
2013年 | 3416篇 |
2012年 | 2758篇 |
2011年 | 3163篇 |
2010年 | 2403篇 |
2009年 | 2269篇 |
2008年 | 2289篇 |
2007年 | 2140篇 |
2006年 | 1879篇 |
2005年 | 1544篇 |
2004年 | 1287篇 |
2003年 | 1054篇 |
2002年 | 796篇 |
2001年 | 739篇 |
2000年 | 653篇 |
1999年 | 630篇 |
1998年 | 443篇 |
1997年 | 406篇 |
1996年 | 375篇 |
1995年 | 345篇 |
1994年 | 326篇 |
1993年 | 259篇 |
1992年 | 221篇 |
1991年 | 186篇 |
1990年 | 179篇 |
1989年 | 143篇 |
1988年 | 167篇 |
1987年 | 170篇 |
1986年 | 163篇 |
1985年 | 204篇 |
1984年 | 206篇 |
1983年 | 120篇 |
1982年 | 133篇 |
1981年 | 121篇 |
1980年 | 120篇 |
1979年 | 104篇 |
1978年 | 92篇 |
1977年 | 89篇 |
1976年 | 85篇 |
1975年 | 90篇 |
1973年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 312 毫秒
41.
Theodore C. Bania MD MS Tom Ashar MD Gregory Press MD Patricia M. Carey MD 《Academic emergency medicine》2003,10(7):697-704
Long-term daily use of gamma-hydroxybutyrate (GHB) and related compounds has recently been associated with a withdrawal syndrome. To the best of the authors' knowledge, there are currently no animal models of GHB withdrawal. OBJECTIVES: The authors studied and described the effect of chronic dosing of GHB (3-6 days) on tolerance and withdrawal in a rat model. METHODS: Rats were administered GHB every three hours via intraperitoneal catheter. Groups of rats (2 per group) were dosed with GHB for either 3 (24 doses), 4 (32 doses), 5 (40 doses), or 6 (48 doses) days. The GHB dose was 0.25 g/kg for doses 1-8, 0.75 g/kg for doses 9-12, 1 g/kg for doses 13-16, 1.25 g/kg for doses 17-24, 1.5 g/kg for doses 25-32, 1.75 g/kg for doses 33-40, and 2 g/kg for doses 41-48. Following the last dose of GHB, the rats were scored using a 16-point ethanol intoxication-withdrawal scale rating spontaneous behaviors, response to handling, grooming, and neurological signs. Lower scores indicate intoxication, while higher scores indicate withdrawal. Scores were recorded at hours 0, 1, 2, 3, 4, 5, 6, 9, 12, and 24. RESULTS: Tolerance: Rats dosed with GHB for more days were less intoxicated one hour after their last GHB dose despite receiving higher doses. WITHDRAWAL: The scores for all rats dosed with GHB increased at hours 4 (p = 0.028), 5 (p = 0.037), 6 (p = 0.007), and 9 (p = 0.024) after the last dose, indicating withdrawal. The scores demonstrated a linear increase dependent upon the number of days of GHB dosing at hours 3 (p < 0.000), 4 (p = 0.004), 5 (p = 0.002), and 12 (p = 0.039) as well as prior to the last dose at hour 0 (p = 0.000). No rats developed seizures. CONCLUSIONS: Tolerance and mild withdrawal in rats can be induced by administering intraperitoneal GHB every three hours for 3-6 days. More prolonged dosing and higher doses of GHB may be necessary to induce severe withdrawal. 相似文献
42.
43.
含左氧氟沙星及卷曲霉素方案治疗耐多药肺结核近期疗效分析 总被引:21,自引:0,他引:21
目的 观察和评价含左氧氟沙星和卷曲霉素联合化疗方案在耐多药肺结核 (MDR PTB)治疗中的疗效。方法 将 177例MDR PTB患者分为治疗组 88例和对照组 89例。化疗方案 :治疗组以左氧氟沙星和卷曲霉素为主 ,联合利福喷汀、异烟肼、对氨基水杨酸钠、吡嗪酰胺 ;对照组用链霉素、乙胺丁醇 ,联用药物同治疗组 ,疗程均为 2 1个月。结果 共有 16 1例患者完成化疗疗程 ,治疗组 82例 ,痰菌阴转率 83% ;对照组 79例 ,痰菌阴转率 5 8% ;痰菌阴转率治疗组明显高于对照组 (P <0 0 1) ;治疗组病灶显效率 5 0 % ,空洞闭合率 6 3% ,治疗组优于对照组 (P <0 0 1) ;治疗组的药物不良反应率为 31% ,对照组为 35 % ,两组比较差异无显著性 (P >0 0 5 )。结论 含左氧氟沙星和卷曲霉素的方案治疗MDR PTB ,有助于痰菌阴转和病变吸收好转 ,药物不良反应低 ,值得在临床上推广应用 相似文献
44.
James H. McKerrow 《Perspectives in Drug Discovery and Design》1995,2(3):437-444
Summary Papain family cysteine proteases function primarily intracellularly in higher eukaryotes, but are often extracellular proteases in protozoan helminths. The utility of this class of enzymes is reflected in the diversity of functions they perform in both parasite life cycles and the pathogenesis of parasitic diseases. Examples include secretion of proteases into the gut of parasitic worms for hemoglobin degradation, release from the surface of nematodes to degrade cuticular proteins during molting, and facilitating excystment of protozoa. 相似文献
45.
103例角膜溃疡的病因和病原及药物敏感试验的统计分析 总被引:7,自引:0,他引:7
对1995年1—12月间我院门诊103例角膜溃疡的病因、病原和药物敏感试验进行统计分析。病因:外伤59例(57.28%),继发感染34例(33.01%),原因不明8例(7.77%),戴接触镜2例(1.94%)。病原:真菌35例(33.98%),绿脓杆菌18例(17.48%),金黄色葡萄球菌15例(14.56%),表皮葡萄球菌9例(8.74%),淋球菌2例(1.94%)。对19例真菌性角膜溃疡同时进行细菌培养,有7例为混合感染,占36.84%。对几种主要检出菌的药物敏感试验表明:它们对普通抗菌素均可产生一定的耐药性 相似文献
46.
BACKGROUND: The responses of mice to the mite allergen Der p 1 have been used to study the mechanisms of allergic sensitization and the development of new types of immunotherapy. Many of the studies require a knowledge of the T cell epitopes, and because Der p 1 is polymorphic, the effect of natural amino acid substitution in the allergen. The intranasal administration of peptides containing T cell epitopes can induce a mucosal tolerance but it is not known if the major activity is limited to stimulatory peptides and if, as found for autoimmunity, some epitopes are not inhibitory. OBJECTIVE: To determine and compare the sequences of Der p 1 which contain stimulatory epitopes for the high responding H-2(b) and H-2(q) mice and the sequences which induce tolerance by intranasal administration of peptides. METHODS: T cell responses of mice immunized with Der p 1 were measured by in vitro T cell stimulation assays so an extensive study of epitope recognition and intranasal tolerance could be made. Synthetic peptides were used to examine the stimulatory and inhibitory ability of all Der p 1 sequences and to map the major H-2(b) epitope in detail. This included the effect of the common polymorphic amino acid 124 substitution found within this epitope. RESULTS: Three and two regions, respectively, were found to contain stimulatory T cell epitopes for H-2(b) and H-2(q) mice. The peptides in these regions were also the most active at inducing intranasal tolerance for the responding haplotype. The correspondence between inhibitory and stimulatory peptides was maintained for the fine mapping of the major H-2(b) epitope. This was found about a core region of 118-126 which was overlapping but separate to a consensus sequence for the binding of endogeneous peptides. Peptides with alanine at the naturally polymorphic residue 124 stimulated and inhibited responses to Der p 1 more effectively, while peptides with the valine 124 variant were immunogenic but poorly cross-reactive. CONCLUSIONS: The intranasal administration of peptides representing each of five epitopes recognized by two strains of mice were able to induce mucosal tolerance and the major tolerizing activity was limited to these epitopes. The position of the core major epitope for C57 mice, which differs from a previously predicted epitope, and its specificity for the natural alanine 124 variant is described. 相似文献
47.
Cocaine-treated rats acquired a preference for cocaine-associated contextual stimuli (CS) relative to saline-injected control rats. However, when animals were given repeated tests for conditioned place preference intermittent between conditioning trials, they displayed an attenuation in strength of conditioning. This attenuation was not due to pharmacologic tolerance (Experiment 1), but rather reflected a disruption in learning due to exposure to the CS alone (Experiment 2). Like other examples of classical conditioning, the strength of the conditioned response (CR) as assessed by the conditioned place preference model may be influenced by partial reinforcement. 相似文献
48.
转hCTLA4Ig树突状细胞诱导T细胞免疫耐受的实验研究 总被引:2,自引:0,他引:2
目的 通过逆转录病毒载体将人CTLA4Ig转染DCs ,探讨转人CTLA4Ig(hCTLA4Ig)树突状细胞 (DCsRev)诱导T细胞免疫耐受的可能性。方法 通过重组逆转录病毒将目的基因hCTLA4Ig转染到大鼠骨髓来源的DCs中 ,通过流式细胞检测目的基因hCTLA4Ig表达及DCs表面分子的改变 ;通过混合淋巴细胞反应 (MLR)检测DCsRev抑制T细胞免疫反应的能力。 结果 重组逆转录病毒转染DCs的最大效率为 91 2 5 % ;在功能上 ,DCsRev不但丧失了刺激MLR的能力 ,并且能够强烈抑制MLR中反应T细胞的增殖 ,而且抑制率与加入DCsRev的数量和DCsRev预处理反应T细胞的时间长短有关。具体来说 ,DCsRev数量在 10 3 ~ 10 4之间时 ,抑制率与剂量呈正相关 ,最高为 71 96%。而当DCsRev数量达到 5× 10 4抑制率下降为 5 9 2 %。在 12~ 48h之间 ,随着预处理时间的延长 ,抑制率却不断下降 ,预处理 12h抑制率最高 ,为 99 6%。但不做预处理 ,在反应开始时同时加入DCsRev ,则抑制率明显降低 ,仅为 5 9 2 %。对腹腔注射DCsRev大鼠脾T淋巴细胞体外分析表明 ,DCsRev也能在动物体内诱导耐受 ,但这种免疫耐受状态不能维持终身。结论 通过逆转录病毒载体将人CTLA4Ig转染DCs,不但DCs表面CD86分子被CTLA4Ig有效的封闭 ,并且能够诱导抗原特异性T细胞的免疫耐受 相似文献
49.
天津医科大学第三医院抗生素类药物的利用分析 总被引:4,自引:0,他引:4
目的:对抗生素类药物利用状况进行分析,以考察应用情况,促进用药合理性,方法:查阅药库2000年药品购入目录,采用药物利用状况分析法,对抗生素用药频度和药物费用等进行分析。结果:该院应用的抗生素主要为头孢菌素,喹诺酮类;DDDs排序靠前的是诺氟沙星,羟氨苄青霉素和复方新诺明等。结论:该院用药基本合理,但水平较低。 相似文献
50.
铁制剂治疗缺铁性贫血的随机对照临床研究 总被引:6,自引:0,他引:6
目的 了解硫酸铁控释片、琥珀酸亚铁、多糖铁复合物治疗缺铁性贫血的疗效及不良反应。方法 将105例不诊于血液科门诊的缺铁性贫血患者,按照入选标准,以随机区组的方法随机分入3个治疗组,分别予以硫酸业铁控释片(福乃得,500mg,每日1次)、琥珀酸业铁(速力菲,,0.1g,每日3次)、多糖铁复合物(力蜚能,0.15g,每日2次)治疗8周,每1-2周随访1次,随访血常规、网织红细胞计数及药物的不良反尖。治疗前及治疗结束检查血清铁、总铁结合力、血清铁蛋白等有关铁参数。结果与结论 以血红蛋白和血清铁蛋白恢复正常作为完全缓解的标准,硫酸亚铁控释片、琥珀酸亚铁、多糖铁复合物3种药治疗8周,缺铁性贫血的完全缓解率分别为74%、76%、40%(P=0.004),总的有效率分别为81%、89%、76%(P>0.05)。主要的不良反应为胃肠道反应,3种药中以多糖铁复合物的不良反应最少,其次为琥珀酸亚铁,硫酸铁控释片的不良反应最常见,但大多数能够耐受。 相似文献